Latest return on equity
Tvardi Therapeutics Return on equity
Direct answer
Tvardi Therapeutics's return on equity is -126.19%.
The verified market snapshot reports -126.19%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 4, 2026.
Get free Tvardi Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -126.19%
Explore related company data
View Tvardi Therapeutics's market capitalizationView Tvardi Therapeutics's price-to-book ratioView Tvardi Therapeutics's 52-week price rangeView Tvardi Therapeutics's profit marginView Tvardi Therapeutics's debt-to-equity ratioView all Tvardi Therapeutics key metricsReturn to Tvardi Therapeutics profile